Source：The Insides Company Limited
On：6th May 2025
Organisation：The Insides Company Limited, Biotech Medical
The Insides Company, a medical technology company focused on the development and commercialisation of novel chyme reinfusion therapy (CRT) devices for the treatment of intestinal failure for both adults and neonatal patients, today announced Biotech Medical, as the exclusive partner for Qatar following the signing of the distribution agreement.
Garth Sutherland, CEO of The Insides Company, commented “we are excited by the opportunity to work with the excellent team at Biotech Medical. From our first meetings during Arab Health and further meetings this year we could see a very good fit. This is a significant step to our global expansion plans as we launch in the Middle East. Commenting on the agreement Ibrahim Parambil Director (Medical Division) Biotech Medical, stated “ Our mission is to meet and exceed client needs by delivering the most advanced and high-quality medical products, consumables, and pharma products and solutions. We have already seen interest in The Insides System after talking with experts in Qatar”
Type II intestinal failure is the inability of the gut to absorb necessary water, macronutrients, micronutrients, and electrolytes to sufficiently sustain life without intravenous supplementation or replacement. This can be due to malabsorption (small bowel mucosal disease), surgical resection (short bowel syndrome), fistulae, dysmotility, or mechanical obstruction. Under the standard care pathway, patients recovering from colorectal surgery often have an enterostomy created to divert intestinal contents (chyme) away from the surgical site as it heals. The enterostomy is typically left open for 6-12 months, and during this time the chyme that is collected is disposed of, which can result in intestinal failure and other complications. The Insides System is a purpose-built medical device for performing chyme reinfusion therapy. Chyme reinfusion is a practice in the management of patients with high-output enterocutaneous fistulas, and high-output enterostomies.
About Biotech Medical
Biotech Medical is a company founded in 2021 with the vision of revolutionizing healthcare by pioneering the integration of unparalleled advancements in healthcare technology sourced internationally aligning with Qatar’s vision.
About The Insides Company
The Insides Company is a provider of life-saving medical devices that are purpose-designed to perform chyme reinfusion therapy for the treatment of patients with severe intestinal failure. The Insides Company’s vision is ‘a world that refeeds’.
Contacts
Biotech Medical
Jowhar Kora Veedu – Division Manager
+974 4435 8130
Email: info@biotechqatar.com
www.biotechqatar.com
The Insides® Company Limited
Garth Sutherland, CEO
Phone：+64 9 887 9309
Email：sales@theinside.co
© 2025 The Insides Company. All copyright, design, patent and intellectual property rights existing in our designs and products and in the images, text and design of our website / marketing material are the property of The Insides Company.
.png){kind=small}
.png){kind=small}
